Healthcare
GP Profile: Equistone banks on experience to ride through the next cycle
As the firm contemplates future fundraising, Unquote speaks to partner Tim Swales about the GPтs current outlook
Ardian exits Unither to GIC, IK-led consortium
Existing investors Keensight and Parquest to remain in share capital alongside company's management
Unigestion holds first close for Direct III, eyes EUR 1bn target
GP is continuing concurrent fundraises for vehicles focused on climate impact and emerging managers.
Nordic Capital holds final close for Fund XI on EUR 9bn
Fund is nearly 50% larger than its predecessor and closed after nine months of roadshow
Platform boot camp: Buy-and-build holds fast in healthcare sector
Healthcare M&A has held up well in 2022 versus 2021, offering hope in a challenging market
Houlihan Lokey poaches Hepberger to bolster healthcare team
Rainer Hepberger spent nine years at William Blair and two at Raymond James; brings expertise in medtech
Trilantic-backed Oberberg's auction delayed on market malaise
Factors including valuation discrepancies and debt markets may have slowed the psychiatry clinic's sale
H2 Equity's Optegra sale advances to second round
UK-based ophthalmology business has received NBOs implying an EBITDA multiple of more than 15x
Palatine exits Veincentre in SBO to CBPE
Sale of varicose vein treatment clinic chain is the second exit from 2016-vintage impact fund
The Bolt-Ons Digest – 17 October 2022
Unquoteтs selection of the latest add-ons with Equistone's Ligentia, Bridgepoint's Infinigate, Ambientaтs Namirial and more
Qualium bets on high dry powder level to sustain exit valuations
Mid-cap sponsor nears EUR 500m Fund III target with closing expected before year-end, source says
Andera Life Sciences closes sixth fund above target on EUR 456m
Fundraising comes as LPs look for more diversification; VC fund will deploy EUR 5m-15m tickets in therapeutics, medtech
Graphite weighs Compass Fostering exit advised by Harris Williams
Sale unlikely to launch soon given downturn in children fostering services space
Financière Arbevel gears up for new life sciences fund first close
With EUR 100m target second vehicle seeks to attract regional entities of French banks
Agilitas bolsters team with two new hires in London
Philip Krinks, Arnaud Moreels join pan-European sponsorтs ESG and investment teams
Down but not out: UK PE market confident in spite of sterling, macro concerns
Sponsors prepare to weather the storm and seize opportunities emerging from the crisis
Novalpina fund exits Laboratoire XO to Stanley Capital
French drug maker is the first divestment from liquidated fund Novalpina I, now managed by Berkeley Research Group
Blisce eyes USD 250m final close for Fund II by Q1 2023
French VC has received USD 220m in commitments for Europe and US-focused growth vehicle
Apposite closes third healthcare fund on GBP 200m
Specialist GP’s Article 8 vehicle tracks six proprietary health impact objectives for investments
Cathay to close latest small-cap fund in early 2023 on up to EUR 350m
Vehicle will target companies with EVs of EUR 40m-EUR 100m and has so far made six acquisitions
GENUI explores Labor Team W exit just a year after labs group buyout
Rothschild hired to assess options after Swiss asset attracted inbound interest from trade
Bridgepoint reviews options for Diaverum advised by Citi
Strategic review follows pulled IPO attempt for Swedish dialysis company in 2020
Holland exits Mauritskliniek in sale to PE-backed Corius
Sale of Dutch dermatology group comes nine months after regulator blocked sale to Triton's Bergman
The Bolt-Ons Digest – 16 September 2022
Unquoteтs selection of the latest add-ons with A&M's Ayesa, BC Partners' Valtech, Advent's IRCA, EQT's IVC Evidensia and more